###### Strengths and limitations of this study

-   Mortality among Belgian workers is investigated using exhaustive census-linked cause-specific mortality data at the individual level.

-   The availability of a large national database allows the study of industries with a relatively small number of workers.

-   Asbestos exposure data is not available for Belgium and could not be included in this study. However, high-risk industries are selected based on an extensive literature review and the strong aetiological relation between mesothelioma and asbestos exposure. A further differentiation is made between manual and non-manual workers.

-   Occupational information is only available for one point in time. Workers exposed before the census date may have been included in the reference population (eg, job change) or may have left the active population (eg, health reasons). Potential confounders after the census date are not taken into account. Our results may underestimate the true influence of occupational asbestos exposure.

Introduction {#s1}
============

Belgium has the fourth highest mesothelioma mortality rate in the world, after the UK, Australia and Italy. Since 2006, over 200 Belgians have died from mesothelioma each year.[@R1] Mesothelioma is considered to be a potent and sensitive indicator of asbestos exposure,[@R2] but further research on other asbestos-related diseases is imperative to understand the full extent of the asbestos problem in Belgium. This study focuses on the primary source of asbestos exposure: the workplace.

Asbestos minerals do not occur naturally in Belgium. With the start of one of Europe\'s largest asbestos companies, Eternit, in the early 1900s, Belgium rapidly became an important supplier of asbestos products. Large amounts of raw asbestos fibres were imported for manufacturing purposes since the 1930s.[@R3] Belgian asbestos industries used a mix of different types of asbestos, usually consisting of 90--99% chrysotile and 10--1% crocidolite.[@R4] The use of relatively small amounts of amosite has also been reported.[@R5]

Asbestos use culminated during the 1960s--1970s, with Belgium having the highest asbestos consumption level per capita in the world.[@R6] Since then, overall exposure levels have gradually decreased as a result of private and public health control measures, including the mandatory use of dust masks and the installation of exhaust systems in the workplace.[@R7] Airborne occupational exposure limits for asbestos were implemented in 1980 to control exposure intensity and duration.[@R8] Nonetheless, these measures did not avert all fatal health effects due to asbestos exposure.

Despite declining asbestos exposure levels, occupational exposure in, for example, asbestos product manufacturing, shipbuilding and construction, remained relatively common until the end of the 1990s. Industrial asbestos use was reduced dramatically with a major ban on all asbestos types in 1998. Some exceptions for chrysotile products remained until 2001, when the use and transaction of all types of asbestos were finally banned.

The few Belgian studies on asbestos health risks in the workplace are based on industry findings, biomedical data or information delivered by victim compensation funds.[@R4] [@R5] [@R9] [@R10] Considering the typical long latency periods of asbestos-related diseases and most occupational asbestos research dating back to the 1960s--1970s, results may not reflect the true public health consequences of industrial asbestos use. Selection bias, differences in diagnostic criteria and low civil awareness of compensation measures, make the representativeness of these data sources questionable.

International studies on the health of asbestos workers focus mainly on well-established asbestos-related diseases, namely asbestosis, malignant mesothelioma and lung cancer. Recently, the International Agency for Research on Cancer has acknowledged a causal effect in the development of laryngeal and ovarian cancer.[@R11] The association between asbestos exposure and several other malignancies remains controversial.

The present study investigates cause-specific mortality among asbestos workers and potentially exposed workers to evaluate potential excess in mortality due to established and suspected asbestos-related diseases. For the first time, mortality follow-up data and individual employment information for a large study population are available to determine the impact of asbestos exposure on Belgian male workers.

Methods {#s2}
=======

Study design {#s2a}
------------

An anonymous record linkage has been performed between detailed occupational information from the 1991 Belgian census and cause-specific mortality data from 1 October 2001 to 31 December 2009. The record linkage was based on a primary link between the 1991 Belgian census, and registration records of all deaths and migrations between the census date (1 March 1991) and 31 December 2009. Then, cause-specific mortality information was derived from death certificates for the period 2001--2009 and added to the dataset. As a result, there is a 10-year time lag between occupational information and cause-specific mortality data.

Death certificates are not available for the 3 Belgian regions. The cause-specific mortality data only covers Flanders and the Brussels Capital Region, where the majority of Belgian asbestos firms were located.[@R1] According to data from the Scientific Institute for Public Health, all-cause mortality in Flanders and Brussels accounts for 65% of all Belgian male deaths in 2003--2010. Approximately 80% of all male mesothelioma mortality occurs among Flemish and Brussels men.[@R12]

Based on the 1991 census, we have identified 1 537 805 occupationally active men (18--65 years) in Flanders and the Brussels Capital Region. Prior to 1 October 2001, 3.5% of these workers emigrated and 3.6% died. Owing to missing occupational information, 30 922 workers could not be classified.

The study investigates 72 074 deaths between 1 October 2001 and 31 December 2009, among a cohort of 1 397 699 Flemish and Brussels men with valid occupational information at the time of the 1991 census.

Classification of high-risk industries {#s2b}
--------------------------------------

The comprehensive character of the census data provides a snapshot of the occupational distribution. Consequently, the risks of persons who have been at least potentially exposed to asbestos can be compared with all other occupational groups. Information about exposure circumstances is not available. Because of the widespread use of asbestos fibres in Belgium, careful consideration is required to distinguish occupational asbestos exposure from environmental or secondary exposure. We have combined the distribution of mesothelioma deaths in Belgian industries with an extensive literature review to determine the industries most at risk of asbestos-related health effects.

Malignant mesothelioma mortality was used as a marker for asbestos exposure (Tenth Revision of the International Classification of Diseases, ICD-10 C45). This highly fatal cancer develops in the protective linings of the lungs, chest wall, abdomen and heart, and is caused almost exclusively by asbestos exposure. Even low levels of asbestos exposure can induce malignant mesothelioma.[@R13] Industrial sectors with at least three mesothelioma deaths during the period 2001--2009 were selected using the Statistical Classification of Economic Activities in the European Community (NACE).

We have cross-referenced these findings with the published literature. An extensive review of international and national studies on occupational asbestos exposure was conducted to ascertain at least potential asbestos use in these industries. Databases PubMed and Unicat (Union Catalogue of Belgian Libraries) have been examined. Keywords included "occupation\*", "industr\*", "asbestos", "health", "mortality", "Belg\*". Additional searches were conducted using the names of the selected industries. Only peer-reviewed articles and government documents were considered. We have made no restrictions in time or language. If industrial asbestos use was established in at least one of the studies, the industry was included in further analyses.

Finally, industries with at least three mesothelioma deaths in the period 2001--2009 and with conclusive evidence of asbestos use were considered as high-risk industries. Three broad categories can be distinguished. [Table 1](#BMJOPEN2014007384TB1){ref-type="table"} presents detailed information on the activities of the analysed industries in each category. Category A includes workers in asbestos industries. Category B includes workers in industries with potential asbestos exposure. Category C consists of workers in all industries excluded from categories A or B.

###### 

Types of industrial activities, per category

  Industry                                                        Industrial activity
  --------------------------------------------------------------- --------------------------------------------------
  \(A\)                                                           
   Asbestos industry                                              Asbestos cement manufacturing
  Asbestos products manufacturing                                 
  \(B\)                                                           
   Automotive industry                                            Manufacture and assembly of car parts
  Manufacture and assembly of motor cycle parts                   
  Repair and maintenance                                          
   Chemical industry                                              Manufacture of basic chemicals
  Manufacture of pesticides and other agrochemical products       
  Manufacture of paints and similar coatings                      
  Manufacture of soap, cosmetics and detergents                   
  Manufacture of other chemical products                          
  Manufacture of man-made fibres                                  
  Manufacture of basic pharmaceutical products                    
   Construction                                                   General construction and demolition
  Construction of buildings and utilities                         
  Civil engineering: roads and water supply                       
  Installation companies                                          
  Final construction work                                         
   Electricity generation and distribution                        Electricity generation and distribution
   Electrotechnical products manufacturing                        Manufacture of electrical appliances
  Assembly and installation of electrotechnical products          
   Manufacture of basic metals                                    Manufacture of basic iron, steel and ferroalloys
  Manufacture of steel tubes, pipes and related fitting           
  Manufacture of other products of first processing of steel      
  Manufacture of basic non-ferrous metals                         
   Metal products manufacturing                                   Casting of metal
  Manufacture of fabricated metal products                        
  Manufacture and assembly structural metal parts                 
  Manufacture of boilers and reservoirs                           
  Grinderies and other                                            
   Railroad industry                                              Railway carriage construction
  Repair and maintenance                                          
  Activities related to railway transport                         
   Shipping industry                                              Shipyards, ship repair and maintenance
  Activities related to inland, maritime and short sea shipping   
   Textile industry                                               Wool, cotton and other
  Carpet, felt and linoleum                                       
  Other activities                                                
  \(C\)                                                           
   Reference population                                           All other workers

A further differentiation was made between manual workers and all other occupational types in high-risk industries. The 1991 census includes information on the type of performed labour: self-employed, blue-collar, white-collar, management, etc. We defined manual workers as blue-collar workers and self-employed persons.^[i](#fn1){ref-type="fn"}^

[Table 2](#BMJOPEN2014007384TB2){ref-type="table"} provides an overview of the number of manual and non-manual workers per industry, together with all-cause mortality and mesothelioma mortality. Of 704 458 manual workers in 1991, 40% were active in high-risk industries. All other occupational types in these industries account for approximately 15% of all 693 241 non-manual workers.

###### 

Mesothelioma deaths and total number of deaths for manual and non-manual workers by industry

                                             Manual workers   Non-manual workers   Total                                          
  ------------------------------------------ ---------------- -------------------- ------- -------- ---- ------ ----------- ----- --------
  \(A\)                                                                                                                           
   Asbestos industry                         1743             16                   121     313      5    18     2056        21    139
  \(B\)                                                                                                                           
   Automotive industry                       52 789           8                    1856    12 057   1    261    64 846      9     2417
   Chemical industry                         21 875           14                   957     18 647   4    882    40 522      18    1839
   Construction industry                     100 297          48                   5341    22 387   16   1333   122 684     64    6674
   Electricity generation and distribution   2164             6                    133     4489     7    277    6653        13    410
   Electrotechnical products manufacturing   15 854           3                    571     12 920   6    462    28 774      9     1033
   Manufacture of basic metals               17 174           11                   748     5209     3    263    22 383      14    1011
   Metal products manufacturing              29 960           9                    1211    6603     2    298    36 563      11    1509
   Railroad industry                         10 840           7                    467     12 352   3    547    23 192      10    1014
   Shipping industry                         12 255           15                   784     3380     1    204    15 635      16    988
   Textile industry                          20 008           3                    1043    3786     2    159    23 794      5     1202
  \(C\)                                                                                                                           
   Reference population                      --               --                   --      --       --   --     1 010 597   249   53 838

D, number of overall deaths; M, number of mesothelioma deaths; N, number of workers.

It is important to bear in mind an undetermined level of asbestos exposure for all categories of workers. Questions on occupational history are not included in the 1991 census. Hence, this research design cannot consider exposure duration or exposure in previous workplaces. In addition, workers may have been exposed to asbestos via the environment or through indirect contact.

Data analysis {#s2c}
-------------

Analyses are performed separately for manual and non-manual workers. Standardised mortality rates (SMRs) are calculated by 5-year age group with reference to workers in all other industries (category C). Lower and upper 95% CI are computed assuming that the observed deaths are Poisson variates. If the observed number of deaths is less than 100, exact limits are calculated directly from the Poisson distribution. For larger numbers, we use the Byar approximation method.[@R14]

Data for the study period 2001--2009 are combined because of the small number of cases per year for some of the industries under investigation. Analyses are based on the underlying cause of death as recorded on the death certificate. Cause-specific mortality is coded using the ICD-10.

Results {#s3}
=======

A total of 996 men died due to mesothelioma from 2001 through 2009. Although previous occupational asbestos exposure is possible, 545 mesothelioma deaths in the non-active population have been discarded from the classification process. One hundred and ninety-four deaths occurred among 173 137 men past the retirement age of 65 years in 1991, and 351 deaths occurred among 510 681 non-active men aged 18--65 years. The selection of high-risk industries is based on a total of 439 mesothelioma deaths in the active population (n=1 397 699).

[Table 3](#BMJOPEN2014007384TB3){ref-type="table"} compares mesothelioma and all-cause mortality in the active and non-active population for men at working ages in 1991. From 2001 to 2009, 21 asbestos workers and 169 potentially exposed workers died due to mesothelioma. Two hundred and forty-nine mesothelioma deaths occurred in the reference population. The high overall mortality among non-active men before age 65 years indicates a "healthy worker effect". Healthy workers remain in the workforce whereas persons with health problems are more inclined to quit prematurely. We restrict further analysis to the active population in 1991.

###### 

Mesothelioma and all-cause mortality in 2001--2009 by activity status for men aged 18--65 years in 1991\*

                                             Mesothelioma   Overall                        
  ------------------------------ ----------- -------------- --------------------- -------- ------------------
  Active population                                                                        
   Asbestos workers              2056        21             2890 (1789 to 4417)   139      116 (97 to 136)
   Potentially exposed workers   385 046     169            141 (121 to 164)      18 097   88 (87 to 90)
   All other workers             1 010 597   249            68 (60 to 78)         53 838   85 (84 to 86)
   Missing information           30 922      12             103 (53 to 180)       2460     118 (114 to 123)
  Non-active population                                                                    
   Pre-retirement                190 090     265            115 (101 to 130)      52 575   108 (108 to 109)
   Unemployed                    86 131      45             130 (95 to 175)       9012     148 (145 to 151)
   Disabled                      25 046      25             140 (91 to 207)       6220     194 (189 to 198)
   Students                      119 742     0              0 (0 to 1678)         642      65 (59 to 69)
   Other                         30 734      2              59 (7 to 214)         1241     152 (143 to 160)
   Missing information           58 938      14             71 (39 to 119)        4912     136 (132 to 139)

\*Reference population: Flemish and Brussels men (18--65 years).

N, number of men; O, observed number of deaths; SMR, standardised mortality ratio.

The results on asbestos-related mortality among asbestos workers and potentially exposed workers are presented in [table 4](#BMJOPEN2014007384TB4){ref-type="table"}, with the SMRs and 95% CIs by occupational type for the period 2001--2009.

###### 

Overall and asbestos-related mortality in selected industries for manual and non-manual workers\*

                     Asbestos industry   Chemical industry   Construction industry   Electrical generation and distribution industry                                                                                                                                                                       
  ------------------ ------------------- ------------------- ----------------------- ------------------------------------------------- ------ ---------------- ----- ----- ------------ ----- ----- ----------- ------ ----- ------------ ------ ----- ------------- ----- ----- ------------- ----- ----- ------------
  All deaths         121                 150                 125 to 180              18                                                80     47 to 126        957   97    91 to 103    882   80    75 to 86    5341   119   116 to 122   1333   100   95 to 106     133   98    82 to 116     277   87    77 to 98
  All neoplasms      61                  174                 133 to 223              13                                                129    68 to 220        416   97    88 to 107    416   86    78 to 95    2399   125   120 to 130   602    105   97 to 114     75    122   96 to 153     131   91    76 to 108
  Laryngeal cancer   1                   182                 5 to 1015               2                                                 1425   173 to 5148      4     60    16 to 155    11    153   76 to 274   61     203   155 to 260   8      95    41 to 187     0     0     0 to 326      2     95    12 to 344
  Lung cancer        21                  175                 108 to 268              1                                                 29     1 to 161         151   103   88 to 121    110   67    55 to 81    995    153   144 to 163   200    104   90 to 119     25    118   76 to 174     33    66    46 to 93
  Mesothelioma       16                  4071                2327 to 6611            5                                                 4489   1458 to 10 476   14    293   160 to 492   4     75    21 to 193   48     227   168 to 302   16     260   149 to 422    6     863   317 to 1878   7     430   173 to 885
  Asbestosis         0                   0                   0 to 21 850             0                                                 0      0 to 59 137      0     0     0 to 1809    0     0     0 to 1487   3      401   83 to 1171   2      843   102 to 3043   0     0     0 to 11 166   0     0     0 to 4692

                     Manufacture of basic metals   Metal products manufacturing   Railroad industry   Shipping industry                                                                                                                                                               
  ------------------ ----------------------------- ------------------------------ ------------------- ------------------- ----- ----------- ------ ----- ------------ ----- ------ ------------ ----- ----- ------------ ----- ----- ----------- ----- ----- ------------ ----- ----- -----------
  All deaths         748                           101                            94 to 109           263                 81    72 to 92    1211   114   108 to 121   298   84     75 to 94     467   112   102 to 122   547   99    91 to 108   784   124   116 to 133   204   94    82 to 108
  All neoplasms      328                           100                            90 to 112           127                 87    72 to 103   498    113   103 to 123   134   87     73 to 103    226   126   110 to 143   223   93    81 to 105   338   121   108 to 134   95    100   81 to 122
  Laryngeal cancer   3                             54                             11 to 158           3                   133   27 to 388   12     163   84 to 285    1     42     1 to 235     7     206   83 to 424    4     93    25 to 238   5     113   37 to 264    0     0     0 to 216
  Lung cancer        127                           112                            94 to 134           29                  57    38 to 82    203    138   119 to 158   47    90     66 to 119    74    122   96 to 153    78    95    75 to 118   136   141   119 to 167   34    106   73 to 147
  Mesothelioma       11                            291                            145 to 520          3                   178   37 to 522   9      187   85 to 354    2     118    14 to 425    7     352   141 to 725   3     112   23 to 327   15    475   266 to 784   1     97    2 to 540
  Asbestosis         0                             0                              0 to 3205           0                   0     0 to 5046   1      710   18 to 3957   1     1654   42 to 9217   0     0     0 to 6301    0     0     0 to 4079   0     0     0 to 2773    0     0     0 to 7192

\*Reference population: manual and non-manual workers in all other industries.

O, observed number of deaths; SMR, standardised mortality ratio.

Asbestos-related mortality {#s3a}
--------------------------

### Asbestos workers {#s3a1}

Mesothelioma mortality is over 40 times higher among manual workers in the asbestos industry than among all other workers (SMR 4071; CI 2327 to 6611). Manual workers also experience 75% more lung cancer deaths than expected (SMR 175; CI 108 to 268). Results on laryngeal cancer mortality are inconclusive, as the ratio is based on only one observed death. No asbestosis deaths occurred among manual workers during the period 2001--2009.

We also find significant excess in asbestos-related mortality for jobs that do not involve direct contact with asbestos fibres. Non-manual workers in the asbestos industry have 45 times higher mesothelioma mortality than expected (SMR 4489; CI 1458 to 10 476). Laryngeal cancer mortality is almost 15 times higher than expected (SMR 1425; CI 173 to 5148). Contrary to their colleagues in manual labour jobs, non-manual workers do not seem to experience higher lung cancer mortality (SMR 29; CI 1 to 161).

### Potentially exposed workers {#s3a2}

Workers from the automotive industry, the electrical products manufacturing industry and the textile industry do not seem to experience significant excess in mortality due to asbestos-related diseases (not shown in [table 4](#BMJOPEN2014007384TB4){ref-type="table"}).

Mesothelioma mortality is significantly higher among manual workers in the electrical generation and distribution industry (SMR 863; CI 317 to 1878), shipping industry (SMR 475; CI 266 to 784), railroad industry (SMR 352; CI 141 to 725), chemical industry (SMR 293; CI 160 to 492), basic metals manufacturing industry (SMR 291; CI 145 to 520) and the construction industry (SMR 227; CI 168 to 302). Manual workers in the metal products manufacturing industry have a SMR of 187 (CI 85 to 354).

Lung cancer deaths are significantly higher than expected among construction workers (SMR 153; CI 144 to 163), shipping workers (SMR 141; CI 119 to 167) and metal products manufacturing workers (SMR 138; CI 119 to 158) in manual labour jobs.

With regard to laryngeal cancer mortality, observed deaths among manual workers in the construction industry are twice as high as expected (SMR 203; CI 155 to 260).

Among all potentially exposed workers in manual labour, four cases of asbestosis deaths have been recorded. Three deaths occurred among construction workers, resulting in an elevated SMR for asbestosis (SMR 401; CI 83 to 1171). One worker in metal products manufacturing died due to asbestosis.

The results for non-manual workers show significant excess in asbestos-related mortality in two industries with potential asbestos exposure. We find significant excess in mesothelioma mortality and asbestosis mortality in the construction industry with SMRs of 260 (CI 149 to 422) and 843 (CI 102 to 3043), respectively. Mesothelioma mortality is more than four times higher among non-manual workers in the electricity generation and distribution industry (SMR 430; CI 173 to 885).

Electricity generation and distribution is also one of three industries with a significant deficit in lung cancer mortality for non-manual workers (SMR 66; CI 46 to 93). The SMRs for lung cancer in the chemical industry and the basic metal manufacturing industry are 67 (CI 55 to 81) and 57 (CI 38 to 82), respectively.

### Other causes of death {#s3a3}

[Table 5](#BMJOPEN2014007384TB5){ref-type="table"} presents the number of deaths from other causes by industry and occupational type, with the corresponding SMRs and 95% CIs. Results indicate significantly more oral cancer deaths among manual workers in the asbestos industry, railroad industry, shipping industry and the construction industry. When examining more closely, high oral cancer mortality is driven by excess deaths due to cancers of the mouth (ICD-10 C01-C06) in all four industries. Mouth cancer mortality is nine times higher among asbestos workers (SMR 938; CI 305 to 2189). Railroad workers experience about four times more mouth cancer deaths (SMR 390; CI 213 to 655). Shipping workers have an elevated SMR of 211 (CI 96 to 400). Construction workers experience 40% more mouth cancer deaths than expected (SMR 140; CI 101 to 189). For construction workers, we also find significant excess in pharyngeal cancer mortality (SMR 151; CI 104 to 212).

###### 

Overall and cause-specific mortality in selected industries for manual and non-manual workers\*

                                Asbestos industry   Chemical industry   Construction industry   Electrical generation and distribution industry                                                                                                                                                                 
  ----------------------------- ------------------- ------------------- ----------------------- ------------------------------------------------- ----- ------------- ----- ----- ----------- ----- ----- ----------- ------ ----- ------------ ------ ----- ------------ ----- ----- ------------- ----- ----- -----------
  All deaths                    121                 150                 125 to 180              18                                                80    47 to 126     957   97    91 to 103   882   80    75 to 86    5341   119   116 to 122   1333   100   95 to 106    133   98    82 to 116     277   87    77 to 98
  All neoplasms                 61                  174                 133 to 223              13                                                129   68 to 220     416   97    88 to 107   416   86    78 to 95    2399   125   120 to 130   602    105   97 to 114    75    122   96 to 153     131   91    76 to 108
  Malignant head and neck       6                   315                 115 to 685              2                                                 436   53 to 1576    19    82    50 to 129   18    74    44 to 117   155    148   126 to 173   32     114   78 to 160    2     64    8 to 233      6     86    32 to 187
  Oral cancer                   5                   383                 124 to 894              0                                                 0     0 to 985      15    95    53 to 157   7     43    17 to 88    89     125   100 to 153   22     116   73 to 176    2     95    12 to 344     4     86    23 to 219
  Mouth                         5                   938                 305 to 2189             0                                                 0     0 to 2351     5     77    25 to 180   3     44    9 to 129    42     140   101 to 189   9      114   52 to 216    0     0     0 to 352      1     52    1 to 287
  Pharynx                       0                   0                   0 to 751                0                                                 0     0 to 2993     3     62    13 to 181   4     73    20 to 187   33     151   104 to 212   7      110   44 to 227    1     164   4 to 912      2     128   15 to 462
  Other head and neck           0                   0                   0 to 5637               0                                                 0     0 to 21 873   0     0     0 to 469    0     0     0 to 431    5      168   55 to 393    2      244   30 to 883    0     0     0 to 3440     0     0     0 to 1516
  Malignant digestive system    7                   76                  31 to 157               1                                                 38    1 to 209      110   98    80 to 118   119   94    78 to 112   561    111   102 to 121   140    93    78 to 109    17    105   61 to 169     36    95    67 to 132
  Oesophageal cancer            2                   128                 16 to 463               0                                                 0     0 to 739      18    95    56 to 150   22    107   67 to 162   112    131   108 to 158   18     75    44 to 118    2     76    9 to 275      9     149   68 to 284
  Stomach cancer                1                   84                  2 to 471                0                                                 0     0 to 899      17    117   68 to 188   10    63    30 to 115   77     118   93 to 148    24     127   81 to 189    4     197   54 to 504     1     21    1 to 118
  Colon cancer                  1                   38                  1 to 214                0                                                 0     0 to 380      33    104   71 to 146   32    87    59 to 123   152    106   90 to 125    33     75    51 to 105    2     43    5 to 156      13    118   63 to 202
  Rectal cancer                 2                   226                 27 to 818               0                                                 0     0 to 1168     13    121   64 to 206   12    99    51 to 173   58     121   92 to 157    19     133   80 to 208    3     192   40 to 562     2     55    7 to 197
  Liver cancer                  0                   0                   0 to 290                0                                                 0     0 to 984      9     72    33 to 136   14    98    54 to 165   53     94    70 to 123    13     77    41 to 131    2     109   13 to 393     3     70    14 to 203
  Pancreas cancer               1                   54                  1 to 298                1                                                 183   5 to 1020     18    79    47 to 125   28    108   72 to 156   101    99    80 to 120    31     100   68 to 142    4     122   33 to 312     8     104   45 to 204
  Other digestive               0                   0                   0 to 3427               0                                                 0     0 to 10 249   2     186   23 to 673   1     72    2 to 402    8      160   69 to 314    2      114   14 to 411    0     0     0 to 1864     0     0     0 to 763
  Malignant urogenital system   6                   159                 58 to 346               2                                                 163   20 to 590     38    82    58 to 113   48    86    63 to 113   216    103   90 to 118    65     94    73 to 120    10    144   69 to 264     19    113   68 to 177
  Prostate cancer               3                   175                 36 to 511               0                                                 0     0 to 498      18    85    51 to 135   27    99    66 to 145   98     101   82 to 123    28     82    55 to 119    5     153   50 to 357     8     100   43 to 196
  Testicular cancer             0                   0                   0 to 13 840             0                                                 0     0 to 92 164   0     0     0 to 1140   0     0     0 to 1726   3      203   42 to 594    2      683   83 to 2469   0     0     0 to 13 444   0     0     0 to 7289
  Bladder cancer                1                   103                 3 to 573                1                                                 322   8 to 1792     10    85    41 to 156   10    70    34 to 129   64     120   92 to 153    17     99    57 to 158    2     111   13 to 402     4     92    25 to 237
  Kidney cancer                 2                   188                 23 to 680               1                                                 324   8 to 1806     10    77    37 to 142   11    76    38 to 135   51     88    66 to 116    18     105   62 to 166    3     160   33 to 468     7     160   64 to 329
  Non-neoplasms                 48                  130                 96 to 173               4                                                 36    10 to 93      430   95    86 to 105   401   76    69 to 84    2313   112   107 to 116   607    94    87 to 102    51    80    59 to 105     127   84    70 to 100
  Circulatory system            27                  131                 86 to 191               2                                                 32    4 to 117      238   94    83 to 107   230   78    68 to 89    1298   113   107 to 119   360    100   90 to 110    31    86    58 to 122     74    87    68 to 109
  Respiratory system            10                  238                 114 to 437              1                                                 70    2 to 391      46    89    65 to 119   36    56    39 to 77    279    118   104 to 132   74     91    72 to 114    4     51    14 to 131     18    95    56 to 150
  Other diseases                11                  91                  46 to 163               1                                                 30    1 to 166      146   99    83 to 116   135   81    68 to 96    736    108   101 to 116   173    85    73 to 99     16    80    45 to 129     35    75    52 to 104
  External code                 12                  141                 73 to 247               1                                                 64    2 to 357      111   104   86 to 125   65    71    55 to 91    629    127   118 to 138   124    111   93 to 133    7     66    27 to 137     19    87    52 to 135

                                Manufacture of basic metals   Metal products manufacturing   Railroad industry   Shipping industry                                                                                                                                                             
  ----------------------------- ----------------------------- ------------------------------ ------------------- ------------------- ----- ----------- ------ ----- ------------ ----- ----- ----------- ----- ----- ------------ ----- ----- ----------- ----- ----- ------------ ----- ----- ------------
  All deaths                    748                           101                            94 to 109           263                 81    72 to 92    1211   114   108 to 121   298   84    75 to 94    467   112   102 to 122   547   99    91 to 108   784   124   116 to 133   204   94    82 to 108
  All neoplasms                 328                           100                            90 to 112           127                 87    72 to 103   498    113   103 to 123   134   87    73 to 103   226   126   110 to 143   223   93    81 to 105   338   121   108 to 134   95    100   81 to 122
  Malignant head and neck       9                             46                             21 to 87            8                   104   45 to 206   37     141   99 to 194    3     37    8 to 109    25    199   128 to 293   16    102   59 to 166   23    150   95 to 225    2     43    5 to 156
  Oral cancer                   6                             44                             16 to 96            5                   96    31 to 225   24     132   85 to 196    2     37    4 to 132    17    192   112 to 308   12    110   57 to 192   18    172   102 to 271   1     32    1 to 179
  Mouth                         3                             54                             11 to 158           3                   139   29 to 407   11     148   74 to 264    2     88    11 to 317   14    390   213 to 655   5     111   36 to 258   9     211   96 to 400    1     77    2 to 429
  Pharynx                       2                             51                             6 to 184            1                   57    1 to 317    9      155   71 to 295    0     0     0 to 162    2     71    9 to 255     1     27    1 to 150    5     157   51 to 367    0     0     0 to 288
  Other head and neck           0                             0                              0 to 588            0                   0     0 to 1410   1      137   3 to 766     0     0     0 to 1302   1     285   7 to 1589    0     0     0 to 700    0     0     0 to 706     1     741   19 to 4131
  Malignant digestive system    87                            102                            81 to 125           39                  101   72 to 138   100    87    71 to 106    40    99    70 to 134   46    98    72 to 131    58    92    70 to 119   74    101   79 to 126    19    76    46 to 119
  Oesophageal cancer            16                            103                            59 to 168           5                   78    25 to 183   22     107   67 to 162    5     74    24 to 174   10    106   51 to 196    11    91    45 to 163   14    112   61 to 187    2     50    6 to 181
  Stomach cancer                12                            109                            56 to 191           3                   62    13 to 182   22     145   91 to 220    4     78    21 to 201   6     98    36 to 213    5     61    20 to 143   12    128   66 to 223    3     96    20 to 280
  Colon cancer                  20                            86                             52 to 132           15                  136   76 to 225   25     79    51 to 117    14    121   66 to 202   10    82    39 to 151    21    124   77 to 190   24    116   74 to 172    7     96    39 to 198
  Rectal cancer                 13                            158                            84 to 270           1                   27    1 to 148    6      55    20 to 120    5     129   42 to 301   5     117   38 to 273    3     52    11 to 151   6     85    31 to 186    1     42    1 to 235
  Liver cancer                  7                             74                             30 to 152           4                   91    25 to 234   10     79    38 to 145    1     22    1 to 122    5     96    31 to 225    6     85    31 to 186   5     60    20 to 141    3     106   22 to 311
  Pancreas cancer               18                            105                            62 to 165           11                  140   70 to 250   15     65    36 to 107    11    133   66 to 238   10    106   51 to 196    11    87    43 to 156   13    87    46 to 149    3     59    12 to 172
  Other digestive               1                             134                            3 to 744            0                   0     0 to 778    0      0     0 to 281     0     0     0 to 693    0     0     0 to 757     1     179   5 to 999    0     0     0 to 425     0     0     0 to 1074
  Malignant urogenital system   26                            80                             52 to 117           19                  116   70 to 181   48     108   80 to 143    16    91    52 to 148   24    147   94 to 218    23    97    62 to 146   40    132   94 to 180    13    115   61 to 197
  Prostate cancer               14                            100                            55 to 169           5                   65    21 to 153   19     98    59 to 152    9     108   49 to 205   6     90    33 to 195    10    98    47 to 181   28    203   135 to 293   8     145   63 to 285
  Testicular cancer             0                             0                              0 to 1621           0                   0     0 to 7102   0      0     0 to 604     0     0     0 to 4339   0     0     0 to 3023    0     0     0 to 2645   0     0     0 to 2329    0     0     0 to 8691
  Bladder cancer                6                             70                             26 to 152           5                   117   38 to 273   10     88    42 to 162    4     89    24 to 229   9     210   96 to 398    2     32    4 to 117    7     90    36 to 185    3     105   22 to 308
  Kidney cancer                 6                             61                             22 to 132           9                   202   92 to 383   19     145   88 to 227    3     65    13 to 190   9     171   78 to 325    11    153   77 to 274   5     59    19 to 137    2     70    8 to 253
  Non-neoplasms                 325                           99                             88 to 110           111                 73    60 to 88    528    112   103 to 122   139   83    70 to 98    195   104   90 to 120    260   103   91 to 117   354   121   109 to 134   92    88    71 to 108
  Circulatory system            184                           100                            86 to 115           68                  79    62 to 100   290    112   99 to 125    84    90    71 to 111   120   116   96 to 139    155   111   94 to 129   195   119   103 to 137   53    90    68 to 118
  Respiratory system            52                            150                            112 to 197          12                  66    34 to 115   68     139   108 to 176   14    70    38 to 117   27    154   101 to 224   24    93    59 to 138   45    134   97 to 179    8     61    26 to 120
  Other diseases                89                            80                             65 to 99            31                  65    44 to 92    170    105   90 to 122    41    76    55 to 104   48    73    54 to 97     81    94    75 to 117   114   120   99 to 144    31    95    64 to 135
  External cod                  95                            115                            93 to 141           25                  100   64 to 147   185    126   108 to 145   25    77    50 to 114   46    89    65 to 119    64    108   84 to 139   92    155   125 to 190   17    102   59 to 163

\*Reference population: manual and non-manual workers in all other industries.

O, observed number of deaths; SMR, standardised mortality ratio.

Significant excess in mortality is found for two other types of malignancies. The SMR for oesophageal cancer mortality among construction workers in manual labour jobs equals 131 (CI 108 to 158). Prostate cancer deaths are two times higher among manual workers in shipping (SMR 203; CI 135 to 293).

Findings also indicate elevated mortality due to diseases of the circulatory system for manual workers in six industries: the asbestos industry, construction industry, basic metals manufacturing industry, metal products manufacturing industry, railroad industry and the shipping industry. Looking at the circulatory diseases separately, we find asbestos workers experience a higher number of deaths caused by cerebrovascular disease (SMR 200; CI 80 to 411) (not shown in [table 5](#BMJOPEN2014007384TB5){ref-type="table"}). Mortality due to ischaemic heart disease is significantly higher among construction workers (SMR 118; CI 109 to 127), shipping workers (SMR 124; CI 100 to 151) and railroad workers (SMR 132; CI 102 to 169) (not shown in [table 5](#BMJOPEN2014007384TB5){ref-type="table"}).

For mortality due to respiratory diseases, we find elevated SMRs for manual workers in the asbestos industry, construction industry, basic metals manufacturing industry, metal products manufacturing industry, railroad industry and the shipping industry. This is due to relatively high numbers of deaths from chronic obstructive pulmonary diseases (COPD). Mortality due to COPD is significantly higher for construction workers (SMR 127; CI 109 to 147), basic metals manufacturing workers (SMR 166; CI 116 to 230), metal products manufacturing workers (SMR 172; CI 128 to 226) and shipping industry workers (SMR 176; CI 124 to 243) (not shown in [table 5](#BMJOPEN2014007384TB5){ref-type="table"}). In addition to elevated mortality due to COPD (SMR 228; CI 84 to 496), results for asbestos workers indicate higher pneumonia mortality (SMR 336; CI 91 to 859) (not shown in [table 5](#BMJOPEN2014007384TB5){ref-type="table"}).

Construction workers in manual labour jobs experience excess mortality due to other diseases, because of a significantly higher number of deaths from alcoholic liver disease (SMR 138; CI 115 to 164, not shown in [table 5](#BMJOPEN2014007384TB5){ref-type="table"}).

Discussion {#s4}
==========

Cause-specific mortality among high-risk workers and all other workers is compared to determine the current impact of asbestos exposure on Belgian workers' mortality. In addition to asbestos workers, 10 types of industrial workers are identified as potentially exposed. Results indicate significant excess in asbestos-related mortality in the asbestos industry and in seven of the selected industries, those being, the chemical industry, construction industry, electrical generation and distribution industry, basic metals manufacturing industry, metal products manufacturing industry, railroad industry and the shipping industry. Contrary to other reports,[@R15] we did not find significant excess risks for asbestos-related mortality in the automotive industry, textile industry or in the electrotechnical industry.

Results clearly show a very high impact of asbestos exposure on asbestos workers. Mesothelioma mortality is 41 times higher among manual workers and 45 times higher among non-manual workers than in the reference population. Significant excess in laryngeal cancer and lung cancer mortality is found for non-manual workers and manual workers, respectively. Working in the asbestos industry seems to entail serious asbestos-related health risks, regardless of the occupational type. It is likely that asbestos exposure in this industry is not confined to specific work-related tasks, but also includes site-related environmental exposure.

Among potentially exposed workers, significant excess in mesothelioma mortality is found for manual work in the chemical industry, the basic metal manufacturing industry and the railroad industry. Surprisingly, manual and non-manual workers in the electricity generation and distribution industry both have a significantly higher number of mesothelioma deaths. This may indicate more widespread asbestos exposure in this industry than expected.

Shipping industry workers in manual labour jobs experience significantly higher mesothelioma and lung cancer mortality. Results also show increased mortality risks for mesothelioma and lung cancer among manual workers in metal products manufacturing, with significant excess in lung cancer deaths.

The construction industry is the only industry with elevated SMRs for all four established asbestos-related diseases. In addition to manual workers, non-manual workers in the construction industry experience significantly higher numbers of mesothelioma and asbestosis deaths. An underestimation of asbestosis mortality is possible because asbestosis is frequently coded as a contributing cause of death, and this study is based on underlying causes of death.

Cause-specific mortality is further scrutinised to identify additional excess in mortality among high-risk workers and evaluate a potential association with asbestos exposure. The results for four industries corroborate a possible association between asbestos exposure and the development of oral cancer. Manual workers in the asbestos industry, construction industry, shipping industry and the railroad industry have significantly higher oral cancer mortality. Tobacco and alcohol consumption are considered to be major risk factors.[@R22] However, occupational asbestos exposure has also been reported as a possible causal factor for oral cancer types,[@R23] and for pharyngeal cancer.[@R26] Historical exposure circumstances should be explored further in order to answer why, specifically, these workers experience high oral cancer mortality.

Reports of elevated prostate cancer risks related to occupational asbestos exposure are scarce.[@R27] [@R28] Krstev *et al*[@R29] found significant excess prostate cancer mortality among unexposed shipping workers. Therefore, a causal effect of asbestos exposure is doubtful.

Potential confounding factors for laryngeal cancer are smoking and alcohol use. Tobacco consumption, a major risk factor for lung cancer, could even have a multiplicative effect when combined with asbestos.[@R30] [@R31] Considering the use of various carcinogens such as nickel, cadmium or PAHs in the selected industries, concomitant occupational exposure is highly likely. Because of insufficient data, potential confounders could not be considered in our analyses. Results do show that manual workers in construction, in basic metal manufacturing, in metal products manufacturing and in shipping, have significantly higher mortality due to COPD, which is known to be caused predominantly by smoking. Occupational exposure to dust, fumes and gases has been associated with increased incidence of COPD.[@R32] Construction workers also experience significant excess in mortality due to alcoholic liver disease, oesophageal cancer, mouth cancer and pharyngeal cancer, suggesting high alcohol use. Although mesothelioma and asbestosis mortality provides clear indications of considerable asbestos-related health effects in these industries, further research is needed to estimate the effect of asbestos exposure on lung cancer and laryngeal cancer mortality.

The main advantage of this study is the availability of census-linked, cause-specific mortality data. The anonymous linkage at the individual level minimises the nominator-denominator bias. Furthermore, even industries with relatively small working populations could be included in this study, due to the large number of persons in the data set.

The study design has some limitations. Occupational information is only available for a specific time period. Our findings may be confounded by exposure during previous jobs. Persons who have already quit asbestos-related industries at the time of the 1991 census cannot be identified. The most heavily exposed workers may have already left the workforce due to health reasons. As only actively employed workers are studied, healthy worker effects may bias our results. Based on the number of mesothelioma deaths among pre-retired men in the non-active population, we believe that a considerable proportion of occupational asbestos victims remain unnoticed.

As a result of job changes prior to the census date, it is also possible that occupationally exposed workers are included in the reference population. Although workers in the reference population are at least partially exposed to asbestos in the environment or through indirect contact, the number of mesothelioma deaths is larger than anticipated. As recent studies estimate that 8.3% to 11% of all mesothelioma deaths are attributable to non-occupational asbestos exposure,[@R33] [@R34] our results may still underestimate the true influence of occupational asbestos exposure.

Occupational information after the 1991 census is not available. Hence, potential confounders related to the last job have not been taken into account. Owing to the long period between asbestos exposure and onset of related diseases, we believe this does not alter the interpretation of our results.

Assumptions on asbestos exposure are industry-based. Although occupational type is considered, individual exposure information is not available and the number of workers at risk is surely overestimated. It is possible that asbestos exposure occurs in some industries only among specific groups of workers at specific workstations, and the effect of occupational asbestos exposure remains unnoticed. This may explain why no significant effects were found for asbestos-related mortality in the automotive industry, the textile industry and the electrotechnical industry.

The distinction between manual and non-manual workers is based on the physical or intellectual nature of the work, as stated in the labour agreement between employer and employee. This criterion is highly subject to interpretation. Reports have been made of workers doing the same job, but with different statuses (blue-collar vs white-collar status).[@R35] [@R36]

In conclusion, cause-specific mortality reveals the repercussions of historical asbestos use on Belgian workers. Asbestos workers are not the only employees to experience increased asbestos-related mortality. The study also identifies eight industries with significantly elevated asbestos-related mortality, which have been previously overlooked in Belgian asbestos research. Furthermore, observations in four industries indicate a possible association between occupational asbestos exposure and the development of oral cancer. This study contributes to the large amount of international evidence on the adverse health effects of occupational asbestos exposure. Workers should be informed about the risks of past exposure and all forms of asbestos use should be banned.
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Self-employed persons constitute a small, but relevant, population in the construction industry (9% of manual workers), automotive industry (5% of manual workers; mainly in repair and maintenance work) and metal products manufacturing (3% of manual workers).
